BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 21287530)

  • 1. Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal.
    Bazan JG; Hara W; Hsu A; Kunz PA; Ford J; Fisher GA; Welton ML; Shelton A; Kapp DS; Koong AC; Goodman KA; Chang DT
    Cancer; 2011 Aug; 117(15):3342-51. PubMed ID: 21287530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK; Mell LK; Schomas DA; Miller RC; Devisetty K; Jani AB; Mundt AJ; Roeske JC; Liauw SL; Chmura SJ
    J Clin Oncol; 2007 Oct; 25(29):4581-6. PubMed ID: 17925552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning.
    Wright JL; Patil SM; Temple LK; Minsky BD; Saltz LB; Goodman KA
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1064-72. PubMed ID: 20350793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoradiation therapy for squamous cell carcinoma of anal canal cancer: report of a case.
    Ando H; Nishimura T; Nakamura T; Sugimura H; Nakamura S
    Radiat Med; 2000; 18(3):199-203. PubMed ID: 10972551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
    Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of advanced anal cancer].
    Norum J; Wist E
    Nord Med; 1992; 107(8-9):227-8. PubMed ID: 1408730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities.
    Edelman S; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):206-11. PubMed ID: 16904522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformal therapy improves the therapeutic index of patients with anal canal cancer treated with combined chemotherapy and external beam radiotherapy.
    Vuong T; Kopek N; Ducruet T; Portelance L; Faria S; Bahoric B; Devic S
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1394-400. PubMed ID: 17276620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
    Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
    Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
    Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy followed by radiotherapy in the treatment of anal cancer.
    Lee DH; Kim I; Song HH; Jung JY; Kim DY; Lee KW; Kim TY; Heo DS; Bang YJ; Ha SW; Park JG; Kim NK
    Oncol Rep; 2003; 10(1):101-4. PubMed ID: 12469152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concurrent chemoradiotherapy for squamous cell carcinoma of the anal canal-report of four cases].
    Kinjo A; Ogawa K; Iraha S; Tamaki W; Toita T; Kakinohana Y; Samura H; Kinjo I; Nishimaki T; Kuniyoshi Y; Murayama S
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):519-22. PubMed ID: 18347409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential and limitations of intensity-modulated radiotherapy in anal cancer.
    Vordermark D
    J Clin Oncol; 2008 Feb; 26(4):688; author reply 688-9. PubMed ID: 18235135
    [No Abstract]   [Full Text] [Related]  

  • 17. [Radiotherapy of carcinomas of the anal canal. Tenon Hospital experience].
    Touboul E; Moureau-Zabotto L; Lerouge D; Pène F; Deniaud-Alexandre E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Schlienger M; Laugier A
    Cancer Radiother; 2003 Nov; 7 Suppl 1():91s-99s. PubMed ID: 15124550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined radio- and chemotherapy of anal cancer].
    Dobrowsky W
    Wien Klin Wochenschr; 1986 May; 98(11):361-5. PubMed ID: 3088846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin-C- or cisplatin-based chemoradiotherapy for anal canal carcinoma: long-term results.
    Olivatto LO; Cabral V; Rosa A; Bezerra M; Santarem E; Fassizoli A; Castro L; Simões JH; Small IA; Ferreira CG
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):490-5. PubMed ID: 20472349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).
    Matzinger O; Roelofsen F; Mineur L; Koswig S; Van Der Steen-Banasik EM; Van Houtte P; Haustermans K; Radosevic-Jelic L; Mueller RP; Maingon P; Collette L; Bosset JF;
    Eur J Cancer; 2009 Nov; 45(16):2782-91. PubMed ID: 19643599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.